Method for the quantitative determination of poloxamers

Details Method for the quantitative determination of poloxamers Method for the quantitative determination of poloxamers

2011-01-11

2011-01-11

Rogers, David A. (Department: 2856)

Measuring and testing

Liquid analysis or analysis of the suspension of solids in a...

Content or effect of a constituent of a liquid mixture

Reexamination Certificate

active

07866203

ABSTRACT:
The invention relates to the analytical determination of poloxamers in a liquid protein sample.

REFERENCES:
patent: 3119740 (1964-01-01), Steelman et al.
patent: 4886750 (1989-12-01), Bertola et al.
patent: 5037751 (1991-08-01), Bertola et al.
patent: 5767067 (1998-06-01), Arpaia et al.
patent: 5981568 (1999-11-01), Kunz et al.
patent: 6306421 (2001-10-01), Kunz et al.
patent: 6358989 (2002-03-01), Kunz et al.
patent: 6433144 (2002-08-01), Morris et al.
patent: 6491938 (2002-12-01), Kunz et al.
patent: 6569441 (2003-05-01), Kunz et al.
patent: 6663881 (2003-12-01), Kunz et al.
patent: 6720350 (2004-04-01), Kunz et al.
patent: 7125843 (2006-10-01), DeFrees et al.
patent: 7157277 (2007-01-01), DeFrees et al.
patent: 7164005 (2007-01-01), Costantino et al.
patent: 7173003 (2007-02-01), DeFrees et al.
patent: 7179617 (2007-02-01), DeFrees et al.
patent: 7214660 (2007-05-01), DeFrees et al.
patent: 7226903 (2007-06-01), DeFrees et al.
patent: 7265084 (2007-09-01), DeFrees et al.
patent: 7265085 (2007-09-01), DeFrees et al.
patent: 7297511 (2007-11-01), DeFrees et al.
patent: 7399613 (2008-07-01), DeFrees et al.
patent: 7462365 (2008-12-01), Costantino et al.
patent: 2001/0014326 (2001-08-01), Andya et al.
patent: 2003/0202972 (2003-10-01), Andya et al.
patent: 2007/0072303 (2007-03-01), Arpaia et al.
patent: WO 91/09955 (1991-07-01), None
patent: WO 98/58957 (1998-12-01), None
patent: WO 01/58493 (2001-08-01), None
patent: WO 2004/087213 (2004-10-01), None
patent: WO 2004/104025 (2004-12-01), None
Cerpa-Poljak, A. et al. “Isoelectric Charge of Recombinant Human Follicle-Stimulating Hormone Isoforms Determines Receptor Affinity and in Vitro Bioactivity”Endocrinology, 1993, pp. 351-356, vol. 132, No. 1.
Dias, J.A. et al. “Receptor Binding and Functional Properties of Chimeric Human Follitropin Prepared by an Exchange between a Small Hydrophilic Intercysteine Loop of Human Follitropin and Human Lutropin”The Journal of Biological Chemistry, Oct. 14, 1994, pp. 25289-25294, vol. 269, No. 41.
Flack, M.R. et al. “Site-directed Mutagenesis Defines the Individual Roles of the Glycosylation Sites on Follicle-stimulating Hormone”The Journal of Biological Chemistry, May 13, 1994, pp. 14015-14020, vol. 269, No. 19.
Hakola, K. et al. “Recombinant rat follicle-stimulating hormone; production by Chinese hamster ovary cells, purification and functional characterization”Molecular and Cellular Endocrinology, 1997, pp. 59-69, vol. 127.
Jewell, R.C. et al. “Pharmacokinetics of RheothRx Injection in Healthy Male Volunteers”Journal of Pharmaceutical Sciences, Jul. 1997, pp. 808-812, vol. 86, No. 7.
Katakam, M. et al. “Effect of Surfactants on the Physical Stability of Recombinant Human Growth Hormone”Journal of Pharmaceutical Sciences, Jun. 1995, pp. 713-716, vol. 84, No. 6.
Keene, J.L. et al. “Expression of Biologically Active Human Follitropin in Chinese Hamster Ovary Cells”The Journal of Biological Chemistry, Mar. 25, 1989, pp. 4769-4775, vol. 264, No. 9.
Klein, J.K. et al. “Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey”Fertility and Sterility, Jun. 2002, pp. 1248-1255, vol. 77, No. 6.
Klein, J. et al. “Development and characterization of a long-acting recombinant hFSH agonist”Human Reproduction, 2003, pp. 50-56, vol. 18, No. 1.
Lapolt, P.S. et al. “Enhanced Stimulation of Follicle Maturation and Ovulatory Potential by Long Acting Follicle-Stimulating Hormone Agonists with Extended Carboxyl-Terminal Peptides”Endocrinology, 1992, pp. 2514-2520, vol. 131, No. 6.
Mao, Y. et al. “Quantitation of poloxamers in pharmaceutical formulations using size exclusion chromatography and colorimetric methods”Journal of Pharmaceutical and Biomedical Analysis, 2004, pp. 1127-1142, vol. 35.
Moghimi, S.M. et al. “Causative factors behind poloxamer 188 (Pluronic F68, Flocor™)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels”Biochimica et Biophysica Acta, 2004, pp. 103-113, vol. 1689.
Valove, F.M. et al. “Receptor Binding and Signal Transduction Are Dissociable Functions Requiring Different Sites on Follicle-Stimulating Hormone”Endocrinology, 1994, pp. 2657-2661, vol. 135, No. 6.

Affiliated with

Also associated with

Rating

Method for the quantitative determination of poloxamers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the quantitative determination of poloxamers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the quantitative determination of poloxamers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2681381